Keywords: sosei, out-licenses, mefloquine, treague, japanese, drug, firm

Sosei out-licenses mefloquine to Treague

Article | 01 December 2008

Print This

Japanese drug firm Sosei Group has out-licensed its intellectual property and know-how relating to the RS(+) isomer of mefloquine to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in